Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2025-12-24 @ 11:47 PM
NCT ID:
NCT01052051
Eligibility Criteria:
Inclusion Criteria:
* Age: ≥ 55 years
* Last menstrual period (LMP): ≥ 4 years
* Good general health
* Willingness to participate in this 4 year long study
* Able to give informed consent
* Able to live independently and travel to the Fremont Area Medical Center (FAMC) for study visits
Exclusion Criteria:
* History of cancer except
* Superficial basal or squamous cell carcinoma of the skin
* Other malignancies treated curatively more than 10 years ago
* History of renal calculi or chronic kidney disease
* History of sarcoidosis
* History of tuberculosis
* Participation in the previous Creighton cancer prevention study
* Mini-Mental Status Exam (MMSE) score of ≤ 23. Use the MMSE if there are any concerns about the person's cognitive abilities or ability to give fully informed consent to the study. Concerns may be related to a person's lack of orientation to person, place, or time; language difficulties (inability to structure simple, complete sentences); or short term memory. The Hartford Institute for Geriatric Nursing recommends that a score of 23 or lower indicates cognitive impairment. (Accessed at www.harforddign.org). See appendix.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
55 Years
Study:
NCT01052051
Study Brief:
Protocol Section:
NCT01052051